Evidence map›Paper›PMID 33880941›Full record

ArticleJournal of the American Heart Association2021

Arterial Platelet Adhesion in Atherosclerosis-Prone Arteries of Obese, Insulin-Resistant Nonhuman Primates.

Eran Brown, Koya Ozawa, Federico Moccetti, Amanda Vinson, James Hodovan, The Anh Nguyen, Lindsay Bader, José A López, Paul Kievit, Gray D Shaw and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [EJNMMI research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 ExpressionCellular and molecular bioengineering · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Eran BrownKnight Cardiovascular Institute Portland OR.
Koya OzawaKnight Cardiovascular Institute Portland OR.
Federico MoccettiKnight Cardiovascular Institute Portland OR.
Amanda VinsonOregon National Primate Research CenterOregon Health & Science University Portland OR.
James HodovanKnight Cardiovascular Institute Portland OR.
The Anh NguyenKnight Cardiovascular Institute Portland OR.
Lindsay BaderOregon National Primate Research CenterOregon Health & Science University Portland OR.
José A LópezBloodworks Research Institute Seattle WA.
Paul KievitOregon National Primate Research CenterOregon Health & Science University Portland OR.
Gray D ShawQuell Pharma Inc. Plymouth MA.
Dominic W ChungBloodworks Research Institute Seattle WA.
Warren OsbornBloodworks Research Institute Seattle WA.
Xiaoyun FuBloodworks Research Institute Seattle WA.
Junmei ChenBloodworks Research Institute Seattle WA.
Jonathan R LindnerKnight Cardiovascular Institute Portland OR.
Bloodworks Northwest · USCardiovascular Institute of the South · USOregon National Primate Research Center · USUniversity of Plymouth · GB

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Targeted CEU Imaging of Atherosclerosis and AngiogenesisR01HL078610 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2022
$6.8M
Molecular and Translational Studies in Hematologic DisordersR35HL145262 · NHLBI · BLOODWORKS · PI LOPEZ, JOSE ARON · 2019 to 2024
$6.5M
Augmentation of Tissue Perfusion with Ultrasound-mediated CavitationR01HL130046 · NHLBI · UNIVERSITY OF VIRGINIA · PI LINDNER, JONATHAN R · 2016 to 2023
$5.5M
The Biology of VWF Self-AssociationR01HL137991 · NHLBI · BLOODWORKS · PI CHUNG, DOMINIC W. · 2017 to 2019
$2.0M
NHLBI NIH HHS R01 HL078610NHLBI NIH HHS R01 HL130046NHLBI NIH HHS R01 HL137991NHLBI NIH HHS R35 HL145262NIH HHS P51 OD011092
6 · The paper itself

Abstract

Background Platelet-endothelial interactions are thought to contribute to early atherogenesis. These interactions are potentiated by oxidative stress. We used in vivo molecular imaging to test the hypothesis that platelet-endothelial interactions occur at early stages of plaque development in obese, insulin-resistant nonhuman primates, and are suppressed by NADPH-oxidase-2 inhibition. Methods and Results Six adult rhesus macaques fed a Western-style diet for a median of 4.0 years were studied at baseline and after 8 weeks of therapy with the NADPH-oxidase-2-inhibitor apocynin (50 mg/kg per day). Six lean control animals were also studied. Measurements included intravenous glucose tolerance test, body composition by dual-energy X-ray absorptiometry, carotid intimal medial thickness, carotid artery contrast ultrasound molecular imaging for platelet GPIbα (glycoprotein- Ibα) and vascular cell adhesion molecule-1, and blood oxidative markers on mass spectrometry. Compared with lean controls, animals on a Western-style diet were obese (median body mass: 16.0 versus 8.7 kg,

Indexed as

AnimalsAtherosclerosisBiomarkersBlood PlateletsCarotid ArteriesCarotid Intima-Media ThicknessDisease Models, AnimalEndothelium, VascularInsulinInsulin ResistanceMacaca mulattaMaleMolecular ImagingObesityPlatelet AdhesivenessVascular StiffnessBiomarkersInsulinatherosclerosismolecular imagingplateletsvon Willebrand factor

Identifiers

PMID33880941
PMCPMC8200741
OpenAlexW3154203781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.